// App-Quantinova.ai

WMP113 2015 ASA : Type and Timing of Venous Thromboembolism Prophylaxis after Intracerebral Hemorrhage

Researchers

Presenter

  • Eric Smith

Principal Investigators

  • Lee Schwamm

  • Gregg Fonarow

  • Ying Xian

  • Jingjing Wu

  • Shyam Prabhakaran

Medical Centers

  • Univ of Calgary, Calgary, Canada

  • Rush Univ Medcl Ctr, Chicago, IL

  • Duke Clinical Research Institute, Durham, NC

  • Feinberg School of Medicine, Northwestern University, Chicago, IL

  • Massachusetts General Hospital, Boston, MA

  • David Geffen School of Medcn at UCLA, Los Angeles, CA

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Intracerebral hemorrhage

  • Venous thrombosis

  • Stroke

Biomarkers

  • Collagen type IV alpha 2 chain

Drug/Treatment

  • Heparin

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim